JP2020512289A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512289A5
JP2020512289A5 JP2019531921A JP2019531921A JP2020512289A5 JP 2020512289 A5 JP2020512289 A5 JP 2020512289A5 JP 2019531921 A JP2019531921 A JP 2019531921A JP 2019531921 A JP2019531921 A JP 2019531921A JP 2020512289 A5 JP2020512289 A5 JP 2020512289A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
cycloalkyl
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019531921A
Other languages
English (en)
Japanese (ja)
Other versions
JP7177059B2 (ja
JP2020512289A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/000094 external-priority patent/WO2018111315A1/en
Publication of JP2020512289A publication Critical patent/JP2020512289A/ja
Publication of JP2020512289A5 publication Critical patent/JP2020512289A5/ja
Application granted granted Critical
Publication of JP7177059B2 publication Critical patent/JP7177059B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019531921A 2016-12-16 2017-12-16 RORγの阻害および他の使用のためのピリミジン三環式エノン誘導体 Active JP7177059B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662435588P 2016-12-16 2016-12-16
US62/435,588 2016-12-16
PCT/US2017/000094 WO2018111315A1 (en) 2016-12-16 2017-12-16 PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES

Publications (3)

Publication Number Publication Date
JP2020512289A JP2020512289A (ja) 2020-04-23
JP2020512289A5 true JP2020512289A5 (cg-RX-API-DMAC7.html) 2021-01-28
JP7177059B2 JP7177059B2 (ja) 2022-11-22

Family

ID=61028153

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019531921A Active JP7177059B2 (ja) 2016-12-16 2017-12-16 RORγの阻害および他の使用のためのピリミジン三環式エノン誘導体

Country Status (19)

Country Link
US (3) US11292781B2 (cg-RX-API-DMAC7.html)
EP (1) EP3555062A1 (cg-RX-API-DMAC7.html)
JP (1) JP7177059B2 (cg-RX-API-DMAC7.html)
KR (2) KR20190110089A (cg-RX-API-DMAC7.html)
CN (1) CN110248932B (cg-RX-API-DMAC7.html)
AU (1) AU2017377852C1 (cg-RX-API-DMAC7.html)
CA (2) CA3223645A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019001658A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019007409A2 (cg-RX-API-DMAC7.html)
EA (1) EA201991387A1 (cg-RX-API-DMAC7.html)
IL (1) IL267274B2 (cg-RX-API-DMAC7.html)
MX (1) MX2019007088A (cg-RX-API-DMAC7.html)
NZ (1) NZ754764A (cg-RX-API-DMAC7.html)
PE (1) PE20191490A1 (cg-RX-API-DMAC7.html)
PH (1) PH12019501371A1 (cg-RX-API-DMAC7.html)
TW (1) TWI831738B (cg-RX-API-DMAC7.html)
UA (1) UA127376C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018111315A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201904227B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS58392B1 (sr) 2008-04-18 2019-04-30 Reata Pharmaceuticals Inc Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
EP2841445B1 (en) 2012-04-27 2017-06-14 Reata Pharmaceuticals, Inc. 2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
AU2016219109B2 (en) * 2015-02-12 2020-05-14 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant iflammation modulators
UA125824C2 (uk) 2016-10-24 2022-06-15 Астразенека Аб 6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
TWI831738B (zh) * 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
CR20190379A (es) 2017-01-30 2019-10-21 Astrazeneca Ab Moduladores del receptor de estrógeno
TW201940165A (zh) * 2018-01-29 2019-10-16 美商卡普勒斯療法有限責任公司 包含6員中心環的srebp抑制劑
US11993574B2 (en) 2018-06-15 2024-05-28 Reata Pharmaceuticals, Inc Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
US20210330653A1 (en) 2020-04-24 2021-10-28 Astrazeneca Ab Dosage Regimen for the Treatment of Cancer
PE20221838A1 (es) 2020-04-24 2022-11-29 Astrazeneca Ab Formulaciones farmaceuticas
CN116096361B (zh) * 2020-08-07 2025-10-10 大鹏药品工业株式会社 新型环烯酮化合物或其盐

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
EP1142889A1 (en) 2000-04-03 2001-10-10 Pfizer Products Inc. Pyrazole derivatives as anti-inflammatory/analgesic agents
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
WO2002047611A2 (en) 2000-11-28 2002-06-20 Board Of Regents, The University Of Texas System Cddo-compounds and combination therapies thereof
JP2005507892A (ja) 2001-09-19 2005-03-24 ファルマシア・コーポレーション 炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
EP1507541A4 (en) 2002-05-13 2009-06-03 Dartmouth College HEMMER AND APPLICATION METHOD THEREFOR
WO2006089406A1 (en) 2005-02-22 2006-08-31 Gemin X Biotechnologies Inc. Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008136838A1 (en) 2007-05-04 2008-11-13 Trustees Of Dartmouth College Novel amide derivatives of cddo and methods of use thereof
US8088824B2 (en) 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
US20090048205A1 (en) 2007-08-15 2009-02-19 Colin Meyer Combination therapy with synthetic triterpenoids and gemcitabine
ME03529B (me) 2008-01-11 2020-04-20 Reata Pharmaceuticals Inc Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
RS58392B1 (sr) 2008-04-18 2019-04-30 Reata Pharmaceuticals Inc Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
HUE033288T2 (en) 2008-04-18 2017-11-28 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
EP2279197B1 (en) 2008-04-18 2014-11-05 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
US8278311B2 (en) 2008-04-28 2012-10-02 Abbott Laboratories Substituted pyrimidine derivatives
ES2449396T3 (es) 2008-07-22 2014-03-19 Trustees Of Dartmouth College Cianoenonas monocíclicas y métodos de uso de las mismas
WO2010053817A1 (en) 2008-11-04 2010-05-14 Trustees Of Dartmouth College Betulinic acid derivatives and methods of use thereof
SG173601A1 (en) 2009-02-13 2011-09-29 Reata Pharmaceuticals Inc Delayed release, oral dosage compositions that contain amorphous cddo-me
AU2011240690C1 (en) 2010-04-12 2014-11-06 Reata Pharmaceuticals Holdings, LLC Method of treating obesity using antioxidant inflammation modulators
ES2653717T3 (es) 2010-12-17 2018-02-08 Reata Pharmaceuticals, Inc. Pirazolil- y pirimidinil-enonas tricíclicas como moduladores antioxidantes de la inflamación
EA026847B1 (ru) 2011-03-11 2017-05-31 Рита Фармасьютикалз, Инк. C4-монометилтритерпеноидные производные и способы их применения
EP2841445B1 (en) 2012-04-27 2017-06-14 Reata Pharmaceuticals, Inc. 2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
TWI630212B (zh) 2012-09-10 2018-07-21 瑞塔醫藥有限責任公司 丁香油素(oleanolic acid)之c17-烷二基與烯二基衍生物及其使用方法
LT2892911T (lt) 2012-09-10 2017-11-10 Reata Pharmaceuticals, Inc. Oleanolinės rūgšties c17 heteroarilo dariniai ir jų panaudojimo būdas
US9278912B2 (en) 2012-09-10 2016-03-08 Reata Pharmaceuticals, Inc. C13-hydroxy derivatives of oleanolic acid and methods of use thereof
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
IL285832B2 (en) 2013-08-23 2024-01-01 Reata Pharmaceuticals Inc Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
WO2015112792A1 (en) * 2014-01-24 2015-07-30 Abbvie Inc. Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
EP3160981B1 (en) * 2014-06-25 2024-01-24 Piramal Enterprises Limited Fused triterpene compounds and uses thereof
WO2016084790A1 (ja) * 2014-11-25 2016-06-02 第一三共株式会社 ヒドロナフトキノリン誘導体
AU2016219109B2 (en) 2015-02-12 2020-05-14 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant iflammation modulators
UA125824C2 (uk) 2016-10-24 2022-06-15 Астразенека Аб 6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
US20200077658A1 (en) 2016-12-16 2020-03-12 Basf Se Pesticidal Compounds
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
WO2018109607A1 (en) 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
TWI831738B (zh) * 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
US11993574B2 (en) 2018-06-15 2024-05-28 Reata Pharmaceuticals, Inc Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith

Similar Documents

Publication Publication Date Title
JP7672451B2 (ja) Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
CN104540835B (zh) 用于治疗血小板聚集的作为蛋白酶激活受体4(par4)抑制剂的咪唑并噻二唑衍生物
TWI923651B (zh) 大環化合物及其用途
KR101462708B1 (ko) 융합된 헤테로시클릭 유도체 및 c-met 억제제로서의 사용 방법
CN113271946A (zh) 官能化杂环化合物作为抗病毒剂
KR101409261B1 (ko) 신규의 복소환 화합물 또는 그 염 및 그 중간체
JP6495915B2 (ja) Tnf活性のモジュレーターとしての縮合イミダゾール及びピラゾール誘導体
CN113831337A (zh) Glp-1受体激动剂及其药物组合物和用途
CN113620945A (zh) Ret抑制剂、其药物组合物及其在药物中的应用
CN113527292A (zh) 一种ret抑制剂、其药物组合物及其用途
CN104583197B (zh) 新型双环吡啶衍生物
CN113527291A (zh) Ret抑制剂、其药物组合物及其用途
JP2020525525A (ja) Rho−関連プロテインキナーゼ阻害剤、rho−関連プロテインキナーゼ阻害剤を含む医薬組成物、当該医薬組成物の調製方法及び使用
US10526323B2 (en) Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
TW201446760A (zh) 作爲β-分泌酶抑制劑之全氟化環丙基稠合1,3-□-2-胺化合物及其用途
TWI891812B (zh) 雙環化合物、包含其的藥物組合物及其應用
KR20120034665A (ko) 야누스 키나제 억제제로서 피라졸?4?일?피롤로[2,3?d]피리미딘 및 피롤?3?일?피롤로[2,3?d]피리미딘의 N?(헤테로)아릴?피롤리딘 유도체
CN110467615A (zh) 吡咯并嘧啶类化合物、包含其的药物组合物及其制备方法和用途
KR20170098324A (ko) 특정 트리아졸로피리딘 및 트리아졸로피라진, 이들의 조성물 및 이들의 사용 방법
CN112955142A (zh) 官能化杂环化合物作为抗病毒剂
US11198687B2 (en) Heteroaryl allosteric modulators of nicotinic acetylcholine receptors
US9675606B2 (en) 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
JP2021518384A5 (cg-RX-API-DMAC7.html)
KR20160142402A (ko) 도파민 d1 리간드로서 헤테로방향족 화합물 및 이의 용도
CN116323617A (zh) 5,6-二氢吡嗪并[2,3-c]异喹啉化合物